Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 5/20 | 0.86 |
| ▸ | AVPR2 | P30518 | 4/20 | 0.86 |
| ▸ | AVPR1B | P47901 | 4/20 | 0.86 |
| ▸ | OXTR | P30559 | 3/20 | 0.86 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desmopressin SCHEMBL29387302 | 0.93 | OXTR (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL29454824 | 0.93 | OXTR (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL22511 | 0.93 | OXTR (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| SCHEMBL31061295 | 0.92 | AVPR2 (0.87) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL1172203 | 0.91 | OXTR (0.97) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL29935850 | 0.91 | OXTR (0.97) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL1171610 | 0.91 | OXTR (0.96) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| SCHEMBL29926492 | 0.87 | AVPR1A (0.85) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Vasopressin SCHEMBL19712236 | 0.86 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Vasopressin SCHEMBL18937546 | 0.86 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068686-A1 | TREATMENT FOR BATTEN DISEASE | THE ROYAL VETERINARY COLLEGE (GB) | 2025-04-03 | — | — | WO | disclosed |